PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

IMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.

Science Immunology, published by the American Association for the Advancement of Science, is a leading journal in the field of immunology, recognized for its significant impact and rigor in advancing our understanding of immune responses and complex diseases. With an impressive impact factor that places it in the Q1 category of both immunology and allergy, as well as miscellaneous medicine, this journal is ranked #7 and #8 in their respective Scopus categories, reflecting its high-quality research output. Since its inception in 2016, Science Immunology has been at the forefront of interdisciplinary immunological research, fostering crucial insights that link immunology with pressing health challenges. The journal is committed to providing open access to its content, ensuring that groundbreaking findings are accessible to a global audience of researchers, professionals, and students. Its anthology not only addresses fundamental immunological mechanisms but also enhances the dialogue on translational applications and therapeutic interventions, solidifying its position as an essential resource within the scientific community.

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Scandinavian Journal of Immunology is a prestigious peer-reviewed journal published by Wiley, focused on the evolving field of immunology and its interdisciplinary ties with medicine. Since its inception in 1972, this journal has cultivated a rich repository of knowledge, showcasing innovative research and reviews that contribute to the understanding of immune system functions, disorders, and therapeutic interventions. With an impressive impact factor reflecting a Q2 ranking in Immunology and a top-tier Q1 status in miscellaneous Medicine categories for 2023, it is recognized for its high-quality scholarly output, positioning it among the leading journals in the field. Additionally, its Scopus ranking of #84 out of 236 in Immunology underscores its significance and relevance to both emerging and established researchers. Although it does not currently offer open access options, the journal’s expansive reach and rigorous publication standards make it an essential platform for disseminating impactful research to the global scientific community. The journal invites submissions that explore the complexities of the immune system, aiming to bridge clinical and basic science for a comprehensive understanding of immunological phenomena.

IMMUNOLOGICAL REVIEWS is a prestigious journal published by Wiley, renowned for its comprehensive and insightful contributions to the field of immunology. Established in 1969, this journal has become an essential resource for researchers, practitioners, and students interested in the latest advancements in immunological science, specifically focusing on both clinical and basic immunology as well as allergy studies. With an impressive Q1 ranking in both Immunology and Immunology and Allergy categories, and a prominent placement in the Scopus ranks (23/233 and 26/236 in their respective fields), this journal consistently showcases high-quality, peer-reviewed articles that significantly impact our understanding of immune responses. Although Open Access options are not available, the journal remains highly valuable, providing in-depth reviews and perspectives that foster further research and dialogue in immunological sciences. With a commitment to excellence, IMMUNOLOGICAL REVIEWS serves as a vital platform for disseminating knowledge, fostering scientific collaboration, and advancing the field toward innovative healthcare solutions.

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

Antibodies is a leading open-access journal published by MDPI since 2012, focusing on the dynamic and rapidly evolving field of immunology and drug discovery. With an E-ISSN of 2073-4468, this esteemed journal aims to provide a platform for the dissemination of high-quality research on all aspects of antibody research, including novel therapeutic strategies, diagnostic applications, and the molecular mechanisms of immune responses. With an impressive portfolio reflecting its standing, Antibodies boasts a 2023 category quartile ranking of Q1 in Drug Discovery and Q2 in both Immunology and Immunology and Allergy. This positions the journal prominently within its field, further underscored by its Scopus rankings that illustrate its influence and relevance, including a rank of #46 out of 157 in Drug Discovery. As a fully open-access journal, Antibodies ensures that groundbreaking research is readily available to a diverse audience, enhancing the collaborative efforts in the scientific community. The journal's headquarters in beautiful Basel, Switzerland, is a testament to its commitment to maintaining high standards of academic excellence while fostering innovation and knowledge exchange among researchers, professionals, and students worldwide.